Pluto Bioinformatics
GSE135997 (mouse): Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcR Expression
Bulk RNA sequencing
Purpose: To understand the molecular mechanisms underlying the CTX synergization with antibody therapies in resistant niche-specific organs and BM-resident tumors SOURCE: Guangan Hu (gahu@mit.edu) - Chen MIT